Michael Haller, MD
Enriched profileProfessor and Chief of the Division of Pediatric Endocrinology, Department of Pediatrics · University of Florida
Michael Haller is Professor and Chief of the Division of Pediatric Endocrinology, Department of Pediatrics at University of Florida. OpenAlex indexes 381 publications with 11,513 citations (h-index 57); ClinicalTrials.gov lists 15 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Pediatric Endocrinology profiles in the findmyKOL directory.
Data verified 18 Oct 2026
Overview
Updated 18 Oct 2026
Michael J. Haller, MD, is Professor and Chief of the Division of Pediatric Endocrinology, Department of Pediatrics at University of Florida. The public record shows 381 publications with 11,513 citations (h-index 57), centered on Diabetes Management and Research, Diabetes and associated disorders, Pancreatic function and diabetes. It also documents an investigator role on 15 registered clinical trials, industry payments reported by 10 companies, 4 NIH-funded awards (2004–2024).
- Most recent indexed publication: 2026 · American journal of epidemiology
- Top research focus: Diabetes Management and Research
- 15 registered trials on ClinicalTrials.gov
- Open Payments reporting from 10 companies
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 51 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 172.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 15 registered studies on ClinicalTrials.gov. The most recent:
- Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- HLA Demographics Study in Adults With Type 1 Diabetes
Sponsor: GentiBio, Inc
- Extension for Community Health Outcomes (ECHO) Diabetes Program
Sponsor: University of Florida
Industry payments
Updated 18 Oct 2026
10 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- SANOFI-AVENTIS U.S. LLCProgram year202513 payments$33,110openpaymentsdata.cms.gov ↗
- Mannkind CorporationProgram year20259 payments$15,181openpaymentsdata.cms.gov ↗
- GENZYME CORPORATIONProgram year20254 payments$11,994openpaymentsdata.cms.gov ↗
NIH funding
Updated 18 Oct 2026
4 NIH research awards on record, funded 2004–2024 per NIH RePORTER. The latest:
- Understanding pancreatic endocrine and exocrine loss in pre-type 1 diabetes
University of Florida
FY2024$615,410R01DK123329 - Understanding pancreatic endocrine and exocrine loss in pre-type 1 diabetes
University of Florida
FY2023$641,052R01DK123329 - Understanding pancreatic endocrine and exocrine loss in pre-type 1 diabetes
University of Florida
FY2021$641,052R01DK123329
Congress activity
Updated 18 Oct 2026
51 congress contributions (2012–2025) across ADA per OpenAlex. The most recent:
- 2076-LB: Combination Proinsulin II-GAD mRNA Lipid Particle Aggregates Delay Diabetes in NOD Mice
ADA Scientific Sessions
ADA2025Co-authorLate-breaking - 2136-LB: Anti-CD3 Antibody Reduces Efficacy of RNA Immunotherapy for Diabetes Prevention in NOD Mice
ADA Scientific Sessions
ADA2025Co-authorLate-breaking - 679-P: Behavioral Health Care Utilization amongst Patients with Insulin-Requiring Diabetes Receiving Care at Federally Qualified Health Centers
ADA Scientific Sessions
ADA2025Co-authorPoster
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 18 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Thyroid autoimmunity and the subsequent development of islet and celiac autoimmunity in the TEDDY study.
American journal of epidemiology
Article2026 - A Phase 2 Trial of Frexalimab, a CD40L Antagonist, in Adolescents and Adults With Recent-Onset Type 1 Diabetes (FABULINUS): Rationale and Study Design.
Diabetes, obesity & metabolism
Article2026
Most-cited works
by citation count (OpenAlex)- 01Identification of tissue-specific cell death using methylation patterns of circulating DNAArticle612 citations2016
- 02
- 03Prevalence of Detectable C-Peptide According to Age at Diagnosis and Duration of Type 1 DiabetesArticle259 citations2014
- 04Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 DiabetesArticle255 citations2020
- 05No Alterations in the Frequency of FOXP3+ Regulatory T-Cells in Type 1 DiabetesArticle253 citations2007
Network
Updated 18 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →endo.pediatrics.med.ufl.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →endo.pediatrics.med.ufl.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →endo.pediatrics.med.ufl.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →endo.pediatrics.med.ufl.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →endo.pediatrics.med.ufl.edu ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →diabetes.ufl.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ufrfprofessors.research.ufl.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →endo.pediatrics.med.ufl.edu ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.drgator.ufl.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.drgator.ufl.edu ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pod.wave.co ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →beyondtype1.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Peter Draganov, MD
University of Florida
Irene Malaty, MD
University of Florida
Laura Jacobsen, MD
University of Florida
Pichapong Tunsupon, MD
University of Florida
Eric Van Cutsem, MD, PhD
University Hospitals Leuven (UZ Leuven)
Josep Tabernero, MD, PhD
Vall d'Hebron Institute of Oncology (VHIO)
Jaffer Ajani, MD
The University of Texas MD Anderson Cancer Center
Charles Fuchs, MD, MPH
Tubulis GmbH